Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by 90guppyon Dec 24, 2020 6:04pm
283 Views
Post# 32181869

RE:RE:PFIZER ARE WATCHING VAXILBIO EXPERIMENTS CLOSELY

RE:RE:PFIZER ARE WATCHING VAXILBIO EXPERIMENTS CLOSELYSix days ago I wrote the post below. Pay attention to my last sentence. Now you have  perfect examples of what I meant with these new strains of covid coming from poor countries where they served as virus depot for mutated strain. Look at these news just a day or two ago.

https://www.thesun.co.uk/news/13560924/south-africa-super-infectious-mutant-covid-strain-second-wave-2/

https://www.chronicle.co.zw/another-new-covid-strain-found-in-nigeria/


90guppy wrote: This pandemic can only be solved if there is an effective vaccine that can be safely and easily transported all over the world. The one that poor countries can afford, one that does not need minus 70C degrees refrigeration because it is impossible for poor countries. Poor countries cannot be left behind in the covid vaccination program otherwise those countries will continue to serve as virus depot and incubator for virus mutations, which will pose the threat of sending them to rich countries.




Charleyfarley wrote:
The significance is understated with USAMRIID




<< Previous
Bullboard Posts
Next >>